29 Garden Street , East Legon, Accra. Ghana.

+233 (0) 303-933-452 or (+233) 553-442-105 info@ammren.org

Eyes On Malaria

slide

Malaria Outbreak in Southern Algeria, a Growing Health Crisis Alongside Diphtheria

Since late September 2024, southern Algeria has been grappling with a severe malaria outbreak, particularly impacting the wilayas of In Guezzam and Bordj Badji Mokhtar, which were previously part of Tamanrasset Province. Following heavy rains in September, stagnant water has created perfect breeding conditions for mosquitoes, resulting in a dramatic […]

slide

Ghana sees falling malaria burden, targets elimination- FRANCIS KOKUTSE

When Eugene Andoh was told that the National Malaria Elimination Programme had set in motion a plan to eliminate malaria in the country, he beamed, made the sign of the cross, and declared, “This must be big news to me. It is something that I have always prayed for. “I […]

slide

World Malaria Day 2024: “Accelerating the fight against malaria for a more equitable world”

Dear malaria partners and friends, On this year’s World Malaria Day, WHO has joined forces with the RBM Partnership and other partners to spotlight the critical importance of advancing health equity, gender equality and human rights in malaria responses worldwide. I would like to begin by acknowledging the tremendous contributions of […]

slide

World Malaria Day 2024: ‘Accelerating the fight against malaria for a more equitable world’

On this World Malaria Day 2024, we unite under the theme “Accelerating the fight against malaria for a more equitable world.” This theme, which is in sync with this year’s World Health Day theme “My Health, My Right’, underscores the urgent need to address the stark inequities that persist in […]

slide

Two new malaria vaccines are being rolled out across Africa: how they work and what they promise

Malaria incidents are on the rise. There were 249 million cases of this parasitic disease in 2022, five million more than in 2021. Africa suffers more than any other region from malaria, with 94% of cases and 95% of deaths worldwide. This year two revolutionary malaria vaccines are being rolled out across […]

slide

Malaria-Transmission-Diagnosis and Treatment

Abstract Malaria is a potentially fatal infectious disease, considered a serious public health problem in the world, caused by a parasite of the Plasmodium genus. It is transmitted by the bite of the infected female Anopheles mosquito, also after blood transfusions, organ transplantation, sharing contaminated syringes in parenteral drug users, […]

slide

New Discovery Unravels Malaria Invasion Mechanism

A recent breakthrough sheds light on how the malaria parasite, Plasmodium falciparum, invades human red blood cells. The study, led by the Swiss Tropical and Public Health Institute (Swiss TPH) and Griffith University’s Institute for Glycomics, reveals the role of a sugar called sialic acid in this invasion process. The […]

slide

The U.S. President Malaria Initiative to Address Malaria in Africa

NORWICH, United Kingdom — The U.S. President Malaria Initiative (PMI) originated in 2005 to help create a world without malaria. The initiative aims to expand proven and highly cost-effective malaria prevention and treatment measures by partnering with country leadership and their National Malaria Control Programs. Here is how the U.S. President Malaria Initiative […]

slide

Transformative Technologies in Vaccine Manufacturing

Vaccines are the most cost-effective strategy to prevent and suppress global infections, such as viral pathogens.Conventional vaccines are classified under three categories: live, attenuated or non-live. Conventional vaccines have shown utility in irradicating smallpox and slowing the spread of other diseases, such as polio, measles, mumps and rubella over past decades.1 However, […]

slide

Nigeria in $124m scramble for malaria vaccine

Nigeria is scrambling for $1.24 billion, about 0.4 percent of its 2024 budget, to procure the R21 malaria vaccine, the full cost to cover an estimated 31 million children aged five and below, BusinessDay analysis shows. The vaccine jointly developed by the Oxford University and Serum Institute of India (SII) covers […]